Literature DB >> 35086100

Risk Factors for Surgery in Pediatric Patients with Crohn's Disease.

Rayna Rumenova Shentova-Eneva1, Denitza Kofinova1, Petyo Hadzhiyski1, Ekaterina Ivanova-Todorova2, Penka Yaneva1, Elena Lazarova1, Mila Baycheva1.   

Abstract

OBJECTIVE: Pediatric Crohn's disease (CD) has a more aggressive phenotype and course than in adults. Many patients develop complications that require surgery. The aim of this study was to identify the factors associated with increased risk for surgical intervention in pediatric patients with CD. SUBJECTS AND METHODS: This study is a retrospective review of medical records. We analyzed the following variables: sex, age at diagnosis, presenting symptoms, duration of symptoms before diagnosis, disease location and severity, the presence of extraintestinal manifestations, and the presence of anti-Saccharomyces cerevisiae antibodies. Univariate analysis using the Mann-Whitney test and Fisher's exact test was performed to detect the factors associated with surgery. Potential risk factors with p < 0.05 were further analyzed using a multivariate binary logistic regression model.
RESULTS: Fifty-seven patients (27 girls and 30 boys) were included in the analysis. More than one-fourth of them (28.1%) required surgical management. Female sex (p = 0.043), disease behavior (p = 0.012), and the presence of perianal disease at diagnosis (p < 0.001) were the variables associated with surgical intervention. Stricturing disease (B2) (odds ratio [OR], 24.944; p = 0.016), stricturing and penetrating disease (B2B3) (OR, 28.276; p = 0.011), and the presence of perianal disease at diagnosis (OR, 95.802; p = 0.001) were independent risk factors for surgery. Female sex was associated with surgery without being an independent risk factor.
CONCLUSION: Females with B2 or B2B3 or the presence of perianal disease at diagnosis are at a higher risk for surgery and should be considered for more aggressive medical treatments.
© 2022 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Pediatric Crohn’s disease; Risk factors; Surgery

Mesh:

Year:  2022        PMID: 35086100      PMCID: PMC9209950          DOI: 10.1159/000522256

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   2.132


  24 in total

1.  Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.

Authors:  Gary R Lichtenstein; Songkai Yan; Mohan Bala; Marion Blank; Bruce E Sands
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

2.  Risk factors for initial surgery in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Stanley A Cohen; Alan G Bostrom; Barbara S Kirschner; Robert N Baldassano; Harland S Winter; George D Ferry; Terry Smith; Oren Abramson; Benjamin D Gold; Melvin B Heyman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

3.  Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohn's disease.

Authors:  Eran Israeli; John D Ryan; Leigh-Anne Shafer; Charles N Bernstein
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-20       Impact factor: 11.382

4.  Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood.

Authors:  James J Ashton; Florina Borca; Enrico Mossotto; Tracy Coelho; Akshay Batra; Nadeem A Afzal; Hang T T Phan; Michael Stanton; Sarah Ennis; Robert Mark Beattie
Journal:  Aliment Pharmacol Ther       Date:  2019-01-09       Impact factor: 8.171

5.  Crohn's disease: influence of age at diagnosis on site and clinical type of disease.

Authors:  J M Polito; B Childs; E D Mellits; A Z Tokayer; M L Harris; T M Bayless
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

6.  Population-based study of surgery in juvenile onset Crohn's disease.

Authors:  D M Sedgwick; J R Barton; D W Hamer-Hodges; S J Nixon; A Ferguson
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

7.  Factors that determine risk for surgery in pediatric patients with Crohn's disease.

Authors:  Marc E Schaefer; Jason T Machan; David Kawatu; Christine R Langton; James Markowitz; Wallace Crandall; David R Mack; Jonathan S Evans; Marian D Pfefferkorn; Anne M Griffiths; Anthony R Otley; Athos Bousvaros; Subra Kugathasan; Joel R Rosh; David J Keljo; Ryan S Carvalho; Gitit Tomer; Petar Mamula; Marsha H Kay; Benny Kerzner; Maria Oliva-Hemker; Michael D Kappelman; Shehzad A Saeed; Jeffrey S Hyams; Neal S Leleiko
Journal:  Clin Gastroenterol Hepatol       Date:  2010-05-31       Impact factor: 11.382

8.  Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease.

Authors:  Amanda Ricciuto; David R Mack; Hien Q Huynh; Kevan Jacobson; Anthony R Otley; Jennifer deBruyn; Wael El-Matary; Colette Deslandres; Mary E Sherlock; Jeffrey N Critch; Kevin Bax; Prevost Jantchou; Ernest G Seidman; Nicholas Carman; Mohsin Rashid; Aleixo Muise; Eytan Wine; Matthew W Carroll; Sally Lawrence; Johan Van Limbergen; Eric I Benchimol; Thomas D Walters; Anne M Griffiths; Peter C Church
Journal:  J Crohns Colitis       Date:  2021-03-05       Impact factor: 9.071

9.  Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

Authors:  Arie Levine; Anne Griffiths; James Markowitz; David C Wilson; Dan Turner; Richard K Russell; John Fell; Frank M Ruemmele; Thomas Walters; Mary Sherlock; Marla Dubinsky; Jeffrey S Hyams
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

10.  The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.

Authors:  Patrick F van Rheenen; Marina Aloi; Amit Assa; Jiri Bronsky; Johanna C Escher; Ulrika L Fagerberg; Marco Gasparetto; Konstantinos Gerasimidis; Anne Griffiths; Paul Henderson; Sibylle Koletzko; Kaija-Leena Kolho; Arie Levine; Johan van Limbergen; Francisco Javier Martin de Carpi; Víctor Manuel Navas-López; Salvatore Oliva; Lissy de Ridder; Richard K Russell; Dror Shouval; Antonino Spinelli; Dan Turner; David Wilson; Eytan Wine; Frank M Ruemmele
Journal:  J Crohns Colitis       Date:  2020-10-07       Impact factor: 10.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.